BB2-50F
BB2-50F is an antimicrobial agent and succinate dehydrogenase and F1Fo-ATP synthase inhibitor. BB2-50F induces ROS. BB2-50F inhibits succinate oxidation and reduces tricarboxylic acid (TCA) cycle activity. BB2-50F inhibits the growth of Mycobacterium tuberculosis H37Rv and its auxotrophic, attenuated derivative mc2 6230 (ΔRD1, ΔpanCD) with an MIC of 8 μM[1].
Product Specifications
CAS Number
[2226086-65-1]
UNSPSC
12352005
Target
Bacterial; Reactive Oxygen Species (ROS) ; Succinate Dehydrogenase
Type
Reference compound
Related Pathways
Anti-infection; Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/bb2-50f.html
Purity
99.52
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(NC(N)=N)C1=NC(C2=CC3=C(O2)C=CC=C3)=C(N4CCCCCC4)N=C1N
Molecular Formula
C20H23N7O2
Molecular Weight
393.44
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Recombinant Cryptococcus neoformans var. neoformans serotype D Patatin-like phospholipase domain-containing protein CNBE2340 (CNBE2340), partial
Recombinant Cryptococcus neoformans var. neoformans serotype D Patatin-like phospholipase domain-containing protein CNBE2340 (CNBE2340), partial
